Bacil Pharma share news, announcements and annual reports
BSE: 524516Pharmaceuticals & BiotechnologySmall Cap
Bacil Pharma Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1994
Last close ₹18.81up ₹0.41 (2.23%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹18.40.
30 Oct: open ₹18.50, high ₹18.99, low ₹18.40
52-week range of traded prices to 30 Oct 2026
₹10.65Low, 26 Aug 2026₹61.80High, 10 Apr 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹27 Cr3,172nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed. Price to book: how it is worked out
- 1.07
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −0.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,126
Bacil Pharma board meetings
152 filed, newest first. Page 2 of 4.
Oct 2024
15 Oct · Board meeting
10 Oct · Board meeting
Meeting on 15 Oct 2024: preferential issue of shares
Sep 2024
27 Sep · Board meeting
23 Sep · Board meeting
Meeting on 27 Sep 2024: increase in authorised capital
Aug 2024
31 Aug · Board meeting
28 Aug · Board meeting
Meeting on 28 Aug 202414 Aug · Board meeting
7 Aug · Board meeting
Meeting on 14 Aug 2024: quarterly results
May 2024
21 May · Board meeting
14 May · Board meeting
Meeting on 21 May 2024: audited results
Feb 2024
5 Feb · Board meeting
Meeting on 13 Feb 2024: quarterly results
Nov 2023
2 Nov · Board meeting
Meeting on 10 Nov 2023: quarterly results
Sep 2023
14 Sep · Board meeting
Aug 2023
7 Aug · Board meeting
Meeting on 14 Aug 2023: quarterly results
May 2023
20 May · Board meeting
8 May · Board meeting
Meeting on 16 May 2023: audited results
Mar 2023
21 Mar · Board meeting
Meeting on 21 Mar 202321 Mar · Board meeting
Feb 2023
11 Feb · Board meeting
2 Feb · Board meeting
Meeting on 11 Feb 2023: quarterly results
Nov 2022
2 Nov · Board meeting
Oct 2022
25 Oct · Board meeting
Meeting on 2 Nov 2022: quarterly results
Sep 2022
Aug 2022
3 Aug · Board meeting
Meeting on 12 Aug 2022: quarterly results
May 2022
23 May · Board meeting
Meeting on 30 May 2022: audited results and quarterly results
Feb 2022
14 Feb · Board meeting
4 Feb · Board meeting
Meeting on 14 Feb 2022: quarterly results
Nov 2021
12 Nov · Board meeting
2 Nov · Board meeting
Meeting on 12 Nov 2021: quarterly results